ANTIPODES PARTNERS Ltd: AEP position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on AEP, newest first. How the timeline and the estimate are built.
ANTIPODES PARTNERS Ltd held 1,699,356 AEP shares at 2026-06-30 per its 13F-HR filed 2026-08-06.
the latest 13F is the newest step
- period ended2026-06-3013F 1,699,356 sharesChange vs previous 13F -110,730 shares
4.26% of the 13F portfolio, value $232,488,894.
13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 1,810,086 sharesChange vs previous 13F -18,884 shares
4.57% of the 13F portfolio, value $237,266,073.
13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,828,970 sharesChange vs previous 13F -347,118 shares
4.43% of the 13F portfolio, value $210,914,344.
13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 2,176,088 sharesChange vs previous 13F +1,044,629 shares
5.49% of the 13F portfolio, value $244,828,369.
13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,131,459 sharesChange vs previous 13F -161,785 shares
3.64% of the 13F portfolio, value $117,409,143.
13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 1,293,244 sharesChange vs previous 13F -93,131 shares
4.43% of the 13F portfolio, value $141,324,110.
13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 1,386,375 sharesChange vs previous 13F +673,644 shares
4.44% of the 13F portfolio, value $127,875,692.
13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 712,731 sharesChange vs previous 13F not available
2.53% of the 13F portfolio, value $73,131,471.
13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).